8 July 2014

Gernandt & Danielsson advises in relation to XVIVO Perfusion’s private placement

Gernandt & Danielsson has advised Pareto Securities AB in its capacity as financial adviser to XVIVO Perfusion AB in connection with an approx. SEK 70 million private placement of shares. 

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. XVIVO Perfusion’s shares are traded on NASDAQ OMX First North. 

Gernandt & Danielsson’s team has mainly consisted of partner Carl Westerberg, senior associate Gustav Skogö and associate Oscar Anderson.